Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Pharm Res. 2015 Dec 1;33(4):868–878. doi: 10.1007/s11095-015-1833-9

Fig. 3.

Fig. 3

Effect of microneedle matrix formulation on HA potency of vaccine. Microneedle patches were fabricated using a vaccine casting solution containing 10 mg/ml trehalose and a matrix casting solution containing different ratios of PVA to sucrose, and were then dried by lyophilization. HA potency was measured immediately after drying. Data show average±s.d. (n=4).